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LETTER TO THE EDITOR
Mucocutaneous leishmaniasis in an 11-year-old girl with
ataxia telangectasia  case report
L
eishmaniasis is a protozoal disease caused by
flagellates of the genus Leishmania and transmit-
ted by sand fly. The reservoir hosts are humans,
dogs, and rodents. It has three different morphological
forms: cutaneous, mucocutaneous (MCL), and visceral.
The different clinical presentations depend on the interac-
tion between parasite species of leishmania and the genetic
and immunological status of the host (1).
Case report
An 11-year-old girl, a known case of ataxia telangectasia,
from Ghaser Libya near Wadi Alkof presented with
complaints of nasal skin lesion of 5 months duration,
followed by purulent rhinitis and destruction of anterior
nose with involvement of adjacent area of skin and upper
lip. Clinically, telangectasia was evident in conjunctivae
(Fig. 1) and skin of face. On walking she had ataxic gait.
She had an ulcerated lesion on the anterior part of nose
with central purulent crust and raised border. Erythema-
tous papulopustular lesions and superficial small ulcers
were seen around the nose, cheeks, upper lip (Fig. 2),
and hard palate. Nasal examination revealed congested
septum, mucopus in nasal cavity, and nasal ulceration
with cartilage destruction. Serology for HIV was neg-
ative. Amastigotes inside macrophage were seen by
Leishman’s stained scraping smears (Fig. 3) and by
Giemsa stained histopathological section (Fig. 4).
Treatment with sodium stibogluconate 20 mg/kg/day
was administered for 28 days with amphotericin 1 mg/kg.
Improvement was only partial, and the patient relapsed
once treatment discontinued.
Discussion
Diagnosis of leishmaniasis is based on criteria that
consider epidemiological data, clinical features, and la-
boratory test results: direct smear, culture and inocula-
tion, biopsy, and PCR (2). Based on the clinical picture,
the immune state of our patient and the geographical area
she came from  Ghaser Libya from where many cases
of cutaneous leishmaniasis had been reported  a
clinicoepidemiological link was made and MCL was
considered as a possible diagnosis, and it was confirmed
by demonstrating the leishmania parasites. MCL is con-
sidered to be a disease of the New World; it is almost
exclusively restricted to South America and is caused
typically by Leishmania braziliensis. In rare cases, it may be
caused by Old World species like L. aethiopica, L. major,
and L. tropica (3, 4).
MCL due to L. infantum had been reported in Mediterra-
nean countries, largely resulting from HIV co-infection (3).
Unfortunately, leishmania species identification was not
possible in our patient as it was not available.
The nasal mucosa is the most affected area, lesions may
be found on the lips, palate, pharynx, and larynx (5), and
in advanced disease progressive tissue destruction and
marked disfigurement may occur (3, 4). MCL requires
Fig. 1. Telangiectasias in the eyes; a marker for diagnosis of
ataxia telangiectasia. Fig. 2. Mucocutaneous leishmaniasis.
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prolonged parenteral treatment with pentavalent antimo-
nials or amphotericin B (2, 5). An increase in treatment
failure has been documented in several regions of the
world (2, 3, 6).
The prognosis of our patient was poor because of late
diagnosis, mucosal involvement, as well as the presence
of underlying primary immune deficiency disease.
Unfamiliarity with the manifestations of MCL caused
a delay in the diagnosis in our patient who has a primary
immune deficiency disease, with consequent spreading to
adjacent skin and mucosa and with inadequate response
to anti-leishmania medications. Well-modulated T-cell
response is needed for resolution of cutaneous lesions,
whereas inadequate cellular immunity may cause uncon-
trolled spread of the parasite and often more severe clinical
forms (6). In addition, a preserved host immune system is
required for a good therapeutic response of leishmaniasis,
since it is caused by an intracellular parasite, and the
antimonial would act only as an immunomodulator (2).
Conclusion
This case is important from a diagnostic point of view
because of its resemblance to other destructing granulo-
matous lesions of the nose as tuberculosis. To the best of
our knowledge, no such case of mucocutaneous leishma-
niasis has been documented previously in ataxia telan-
gectasia as a primary immune deficiency disease. Also,
the 11-year-old’s case is the first case of mucocutaneous
leishmaniasis reported from Libya that not only merits
documentation but also mandates further research into
the epidemiology, geographic distribution, and inter-
species interactions of the leishmania parasite.
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Fig. 3. Amastigotes inside macrophage in Leishman’s stained
smear.
Fig. 4. Amastigotes were evident by Giemsa stained
histopathology (high power).
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